Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (4)	2/2/1998 2:52:00 PM
From: James Silverman	Read Replies (1) of 4974

Rick, sec.gov Just wanted to encourage anyone interested to read through the latest Genta SEC filing. I just found it incredibly insightful into how low priced issues that are cash strapped often lead to massive dilution. Unfortunately its the small individual investors that are the one's that get blindsided, while those supplying the company cash often make out very handsomely, far better than may meet the eye. One can draw their own conclusions as to whether Aries/Paramount are one's to invest with. I've followed Lampert via Barron's for several years now. He's had his winners and losers. SEPR, GLFD, INCY to name a few of his big winners. GNTA (pre-pre cash starvation days), AIMM to name a couple of losers. Note I would venture to guess he's long gone from both GNTA and AIMM, probably taking a bath in GNTA, but may well have made money as it did climb smartly prior to its falling off a cliff last year. From all accounts, Lampert has possibly the best long term track record out there in biotech. Feel free to add me to your guest list. jimmysil@email.msn.com Thanks Rick for starting this interesting thread. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next